Atlantic Equities analyst Steve Chesney maintains Johnson & Johnson (NYSE:JNJ) with a Neutral and raises the price target from $160 to $168.
No More Weed Schemes: Pot Retailers Can No Longer Use Cashless ATMs, What Now & Why SAFE Might Not Be The Answer
For years, some if not most cannabis retailers have been obliged to employ a workaround to function within the restrictive system. Now, that is no longer an option.
